Market Eyes LiveUnitedhealth Group Incorporated (UNH) Stock Rating & Analysis
MELANY's data-driven read on Unitedhealth Group Incorporated · Hospital & Medical Service Plans.
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. A leader in employer-sponsored, self-directed, and government-backed plans, it has large scale in medical insurance, and its Optum franchises extend the company across pharmaceutical benefits, outpatient care, and analytics for affiliates and third parties.
Why UNH scores 63/100
MELANY scores Unitedhealth Group Incorporated 63/100 by weighing eight factors. Here is how UNH breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- Forward P/E 17.0x, earnings growth accelerating
- PEG ratio 1.20 (< 1 = undervalued)
- FCF yield 7.0%
Margins, returns on capital, and balance-sheet strength.
Direction and relative strength of the recent share-price trend.
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 3 of last 4 quarters
- Avg EPS beat +10%
What Wall Street price targets and revisions are signalling.
- Institutional net buying +3.2%
Near-term events that could move the stock.
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Key risks for UNH
- No specific company-level red flags detected, monitor macro regime changes
Sector and theme context
Unitedhealth Group Incorporated sits in the Healthcare sector theme, which MELANY currently rates 42/100 for strength. Theme strength feeds UNH's momentum and catalyst factors above.
Tracking UNH
Unitedhealth Group Incorporated rates Hold right now, so MELANY is not flagging a fresh entry. Create a free account to add UNH to your watchlist and get alerted the moment the rating changes.
How MELANY rates UNH
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Unitedhealth Group Incorporated's 63/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about UNH
Is Unitedhealth Group Incorporated (UNH) a buy?
As of 2026-08-21, MELANY rated Unitedhealth Group Incorporated Hold with a composite score of 63/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Unitedhealth Group Incorporated's MELANY score?
Unitedhealth Group Incorporated (UNH) has a MELANY composite score of 63/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, and macro fit.
How is the UNH stock rating calculated?
MELANY scores UNH from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Unitedhealth Group Incorporated stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Unitedhealth Group Incorporated (UNH) Hold with a composite of 63/100 as of 2026-08-21. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the UNH stock price forecast?
MELANY does not publish price targets or forecasts for UNH. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 63/100 across eight factors for Unitedhealth Group Incorporated, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is UNH stock overvalued or undervalued?
MELANY's valuation factor currently reads 63/100 for Unitedhealth Group Incorporated, where a higher score means the price looks more attractive against earnings, growth, and peers. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives UNH's read.
What price should I buy UNH at?
MELANY is not flagging a fresh entry for UNH at its current Hold rating, so there is no entry zone to publish right now. Watchlisting UNH in the free app gets you alerted the moment that changes.
What are the risks of buying UNH stock?
The top risks MELANY currently flags for Unitedhealth Group Incorporated: No specific company-level red flags detected, monitor macro regime changes. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Unitedhealth Group Incorporated a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 41/100 for Unitedhealth Group Incorporated, and earnings track record, at 84/100. The 63/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will UNH stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 65/100 for UNH right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this UNH rating?
The rating on this page is a snapshot of MELANY's read as of 2026-08-21. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores UNH continuously as new price, earnings, and fundamental data arrive, and that current rating is free in the app.
UNH's live rating and alerts are free either way. The app is our flagship.